FDA Clarifies User Fee Refund Policy, MDUFMA Performance Goals

FDA's adherence to user fee performance goals will be measured by "FDA days"- the amount of time a premarket application is pending at the agency - rather than by total review times, HHS clarifies in a November presentation to Congress

More from Archive

More from Medtech Insight